News from armas pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 16, 2020, 08:38 ET Armas Pharmaceuticals COVID-19 Statement

In our role as a U.S. Healthcare Provider, Armas Pharmaceuticals Inc. (Armas) is working diligently with our international partners during the...


Jan 20, 2020, 08:34 ET Armas Pharmaceuticals Adds Four Generic Injectables As First Launches of 2020

Armas Pharmaceuticals Inc. (Armas), has begun the new year with launches of four generic injectables: Caffeine Citrate, Docetaxel, Gemcitabine and...


Nov 13, 2019, 08:35 ET Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib

Armas Pharmaceuticals Inc. (Armas) is announcing the launch of generic Tarceva® (a trademark of Genentech USA, Inc) Tablets. Erlotinib is now...


May 28, 2019, 08:46 ET Armas and Micro Labs Announce Collaboration To Launch Generic Injectables to U.S. Market

Armas Pharmaceuticals Inc. and Micro Labs USA, Inc. have announced today, the forming of a strategic collaboration to bring select multisource...


Nov 19, 2018, 09:04 ET Armas Pharmaceuticals Announces the Launch of Their First Injectable Product to U.S. Market

Armas Pharmaceuticals Inc. (Armas), a NJ based multisource pharmaceutical corporation, is announcing the launch of their first injectable to the U.S. ...